08:00 , Feb 3, 2014 |  BC Week In Review  |  Clinical News

Agenmestencel-T: Phase I/II started

Apceth began the European Phase I/II TREAT ME trial to evaluate IV agenmestencel-T in about 28 patients. Apceth GmbH & Co. KG, Munich, Germany   Product: Agenmestencel-T, MSC_apceth_101   Business: Cancer   Molecular target: NA   Description:...
07:00 , Jun 17, 2013 |  BC Week In Review  |  Clinical News

Agenmestencel-T: Phase I/II start

This month, Apceth will begin an open-label, German Phase I/II trial to evaluate agenmestencel-T in 28 patients. Apceth GmbH & Co. KG, Munich, Germany   Product: Agenmestencel-T, MSC_apceth_101   Business: Cancer   Molecular target: NA   Description:...